An essential tool for detection of respiratory illnesses

By performing just a single test healthcare personnel is now able to simultaneously detect eighteen of the most prevalent respiratory infections in patients. The Seeplex 18-plex Respiratory Test is a highly economical method for molecular diagnostics of respiratory infections. It achieves results rapidly at minimal costs per test.

Photo: An essential tool for detection of respiratory illnesses

Seegene invents its new Seeplex 18-plex Respiratory Test as an essential tool for active surveillance and treatment of respiratory illnesses. Compared to the usual ‘single pathogen – single test’ testing regime the new multiplex-formatted diagnostic test, for which nasopharyngeal spirates, nasopharyngeal swabs or bronchoalveolar lavage samples could be used, is cost-effective and delivers fast results.

The Test detects the following  RNA viruses, DNA viruses and pneumonia bacteria:

      -          Influenza A virus
-          Influenza B virus
-          Human respiratory syncytial virus A
-          Human respiratory syncytial cirus B
-          Human parainfluenzae virus 1
-          Human parainfluenzae virus 2
-          Human parainfluenzae virus 3
-          Human coronavirus 229E/NL63
-          Human coronavirus OC43/HKU1
-          Human rhinovirus
-          Human enterovirus
-          Human adenovirus
-          Human bocavirus
-          Legionella pneumoniae
-          Streptococcus pneumoniae
-          Chlamydophila pneumoniae
-          Haemophilus influenzae
-          Mycoplasma pneumoniae

14.09.2007

More on the subject:

Related articles

Photo

News • Acute myeloid leukaemia

Six-gene scoring system could help predict AML survival

Acute myeloid leukaemia (AML) has widely variable outcomes from one patient to the next. Now, researchers have created a new scoring system based on the activity of six different genes to help…

Photo

Sponsored • Connecting Precision Medicine with Smart Healthcare

Taipei Brings Six Biomedical Innovations to MEDICA 2026

Six Taipei-based biomedical companies will showcase innovations in precision medicine and smart healthcare at MEDICA 2026 (November 16–19, Düsseldorf).

Photo

News • Trial investigates combined benefits

Liquid biopsy and mammography: a perfect match for breast cancer detection?

Could a liquid biopsy blood test help detect breast cancer earlier than a mammogram alone? A new clinical trial to evaluate this question has just started.

Subscribe to Newsletter